Cargando…
The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
The omega-3 fatty acid (n-3 FA) eicosapentaenoic acid (EPA) reduces stroke in patients with atherosclerotic cardiovascular disease. Whether EPA affects stroke or cerebral small vessel dis-ease in patients with atrial fibrillation (AF) remains uncertain. EPA, docosahexaenoic acid (DHA), docosapentaen...
Autores principales: | Reiner, Martin F., Baumgartner, Philipp, Wiencierz, Andrea, Coslovsky, Michael, Bonetti, Nicole R., Filipovic, Mark G., Montrasio, Giulia, Aeschbacher, Stefanie, Rodondi, Nicolas, Baretella, Oliver, Kühne, Michael, Moschovitis, Giorgio, Meyre, Pascal, Bonati, Leo H., Lüscher, Thomas F., Camici, Giovanni G., Osswald, Stefan, Conen, David, Beer, Jürg H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922349/ https://www.ncbi.nlm.nih.gov/pubmed/33671288 http://dx.doi.org/10.3390/nu13020651 |
Ejemplares similares
-
Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
por: Baumgartner, Philipp, et al.
Publicado: (2023) -
Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation
por: Reddiess, Philipp, et al.
Publicado: (2021) -
Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients
por: Krisai, Philipp, et al.
Publicado: (2021) -
Blood Pressure and Brain Lesions in Patients With Atrial Fibrillation
por: Aeschbacher, Stefanie, et al.
Publicado: (2020) -
Long-term risk of adverse outcomes according to atrial fibrillation type
por: Blum, Steffen, et al.
Publicado: (2022)